The year 2013 brought a new series of challenges for pharma. As the dust settled following the bulk of major …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

